- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 253/07 - 1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 253/07
Total number of patents in this class: 153
10-year publication summary
|
10
|
11
|
5
|
11
|
3
|
7
|
12
|
20
|
7
|
11
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Corteva Agriscience LLC | 2669 |
8 |
| Hoffmann-La Roche Inc. | 3418 |
7 |
| F. Hoffmann-La Roche AG | 7925 |
6 |
| Mitsubishi Tanabe Pharma Corporation | 579 |
6 |
| Nxera Pharma UK Limited | 169 |
6 |
| Bayer Cropscience AG | 2035 |
5 |
| Oryzon Genomics S.A. | 106 |
5 |
| University of Greenwich | 71 |
5 |
| Bayer AG | 3330 |
4 |
| Takeda Pharmaceutical Company Limited | 2713 |
4 |
| Arena Pharmaceuticals, Inc. | 366 |
4 |
| Incyte Holdings Corporation | 660 |
4 |
| Symrise AG | 1722 |
4 |
| Boehringer Ingelheim Vetmedica GmbH | 1270 |
3 |
| Health Research, Inc. | 343 |
3 |
| Institut National des Sciences Appliquees de Rouen (insa) | 27 |
3 |
| Nihon Nohyaku Co., Ltd. | 327 |
3 |
| The Regents of the University of California | 19918 |
2 |
| Allergan, Inc. | 2349 |
2 |
| Centre National de La Recherche Scientifique | 10418 |
2 |
| Other owners | 67 |